BioNTech SE Financial Flexibility Index
BioNTech SE financial flexibility index. BioNTech SE (22UA) has a Financial Flexibility Index of -0.14x as of March 2026. Free cash flow of €-342.10 Million (operating CF €-421.00 Million minus capex €78.90 Million) represents 0% of total liabilities (€2.38 Billion). See 22UA free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of BioNTech SE (2017–2025)
Financial flexibility index of BioNTech SE from 2017 to 2025. Historical Financial Flexibility Index trend for BioNTech SE across 9 annual periods. Check BioNTech SE (22UA) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
BioNTech SE Financial Flexibility Index by Year (2017–2025)
BioNTech SE financial flexibility index by year from 2017 to 2025. Year-by-year free cash flow to debt coverage for BioNTech SE. For the full cash flow conversion analysis, see 22UA cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | €1.21 Billion | €456.00 Million | €2.76 Billion | ▲ +106.0% |
| 2024 | 0.21x | €660.00 Million | €207.70 Million | €3.12 Billion | ▼ -90.4% |
| 2023 | 2.20x | €6.08 Billion | €5.37 Billion | €2.76 Billion | ▼ -49.1% |
| 2022 | 4.32x | €13.94 Billion | €13.58 Billion | €3.22 Billion | ▲ +1573.9% |
| 2021 | 0.26x | €1.02 Billion | €889.70 Million | €3.94 Billion | ▲ +365.9% |
| 2020 | 0.06x | €52.50 Million | €-13.50 Million | €946.77 Million | ▲ +110.5% |
| 2019 | -0.53x | €-159.90 Million | €-198.50 Million | €304.15 Million | ▼ -600.3% |
| 2018 | -0.08x | €-28.98 Million | €-58.88 Million | €385.99 Million | ▼ -12.4% |
| 2017 | -0.07x | €-28.24 Million | €-52.56 Million | €422.92 Million | — |